Related Experiment Video
Updated: Feb 23, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
Sample preparation composite and replicate strategy case studies for assay of solid oral drug products
Beverly Nickerson1, Brent Harrington2, Fasheng Li2
1Pfizer Worldwide Research and Development, Analytical Research and Development, 558 Eastern Point Road, Groton, CT 06340, United States.
Abstract:
Drug product assay is one of several tests required for new drug products to ensure the quality of the product at release and throughout the life cycle of the product. Drug product assay testing is typically performed by preparing a composite sample of multiple dosage units to obtain an assay value representative of the batch. In some cases replicate composite samples may be prepared and the reportable assay value is the average value of all the replicates. In previously published work by Harrington et al. (2014) [5], a sample preparation composite and replicate strategy for assay was developed to provide a systematic approach which accounts for variability due to the analytical method and dosage form with a standard error of the potency assay criteria based on compendia and regulatory requirements. In this work, this sample preparation composite and replicate strategy for assay is applied to several case studies to demonstrate the utility of this approach and its application at various stages of pharmaceutical drug product development.
Related Concept Videos
Bioequivalence studies: Biowaivers
In Vitro Drug Dissolution: Compendial Testing Models I
In Vitro Drug Dissolution: Compendial Testing Models II
Clinically Relevant Drug Product Specifications: Methods of Establishment
Sample Preparation for Analysis: Overview
Bulk or large solid samples are typically reduced in size using grinding, crushing, or milling techniques to increase the...
Drug Dissolution: Requirements and Profile Comparison

